Search Results - "Cros, Agnés"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study by Kousignian, Isabelle, Sautereau, Aurélie, Vigouroux, Corinne, Cros, Agnès, Kretz, Sandrine, Viard, Jean Paul, Slama, Laurence

    Published in PloS one (14-05-2021)
    “…Diabetes mellitus (DM) is a major and increasing public health problem that may be underdiagnosed and undertreated among persons living with HIV (PLWH). To…”
    Get full text
    Journal Article
  2. 2

    Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: A prospective study in outpatient clinics in the Paris region by Kolakowska, Agnieszka, Marshall, Esaïe, Krastinova, Evguenia, Cros, Agnès, Duvivier, Claudine, Leroy, Pierre, Caby, Fabienne, Zucman, David, Maka, Arthur, Salmon, Dominique, Chéret, Antoine

    Published in Vaccine (20-06-2024)
    “…Vaccine prevention strategies play a crucial role in the management of people living with HIV (PLWH). The aim of this study was to assess vaccination coverage…”
    Get full text
    Journal Article
  3. 3

    Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users by Slama, Laurence, Porcher, Raphael, Linard, Françoise, Chakvetadze, Catherine, Cros, Agnès, Carillon, Séverine, Gallardo, Lucille, Viard, Jean-Paul, Molina, Jean-Michel

    Published in BMC infectious diseases (17-02-2023)
    “…The use of long acting injectable (LAA) antiretroviral drugs may be an alternative option for HIV treatment and prevention. Our study focused on patient…”
    Get full text
    Journal Article
  4. 4

    Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users' ambivalences by Carillon, Séverine, Gallardo, Lucille, Linard, Françoise, Chakvetadze, Catherine, Viard, Jean-Paul, Cros, Agnès, Molina, Jean-Michel, Slama, Laurence

    Published in AIDS care (13-05-2020)
    “…Recent clinical trial data showed that injectable long-acting antiretroviral treatment (LA-ART) every four or eight weeks could become an alternative option…”
    Get full text
    Journal Article